CORRESP 1 filename1.htm

 

 

 

Biofrontera Inc. · 120 Presidential Way, Suite 330 · Woburn, MA 01801 · USA

 

VIA EDGAR

 

October 20, 2021

Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

 

Attn: Abby Adams
  Suzanne Hayes
  Tara Harkins
  Brian Cascio

 

Re: Biofrontera Inc.
  Registration Statement on Form S-1, as amended (File No. 333-257722)
  Withdrawal of Prior Acceleration Request

 

Ladies and Gentlemen:

 

Reference is made to our letter, filed as correspondence with the U.S. Securities and Exchange Commission via EDGAR on October 18, 2021, in which we requested the acceleration of the effective date of the above-captioned Registration Statement, as amended, to 4:30 p.m., Eastern time, on October 19, 2021. We are no longer requesting that the Registration Statement be declared effective at that date and time, and we hereby formally withdraw our prior request for acceleration of the effective date of the above-captioned Registration Statement, as amended.

 

  Very truly yours,
   
  Biofrontera Inc.
     
    /s/ Erica Monaco
  Name: Erica Monaco
  Title: Chief Financial Officer and Chief Operating Officer

 

cc: Hermann Luebbert  
  Biofrontera Inc.  
     
  Stephen Older  
  McGuireWoods LLP  

 

Biofrontera Inc. . 120 Presidential Way, Suite 330 . Woburn, MA 01801 . USA
Contact Phone +1 781 245 1325 . E-Mail info-us@biofrontera.com .
www.biofrontera.us.com

Board of Directors Prof. Dr. Hermann Luebbert (CEO & Chair) . Erica Monaco (CFO & COO)